LH10 is an FXR agonist based on fexaramine, with an EC50 of 0.14 µM. It offers hepatoprotective effects, mitigating conditions such as cholestasis induced by alpha naphthylisothiocyanate (ANIT), acute liver injury caused by APAP, and non-alcoholic steatohepatitis (NASH).
Molekulargewicht:
515.64
Formel:
C34H33N3O2
Target-Kategorie:
FXR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
